Study ID: TVP-1012/PM106
Study Title
- ParFemale, Maleel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease
Teva Identifier
- TVP-1012/PM106
ClinicalTrials.gov Identifier
- NCT01723228
Study Status
- Completed
Trial Condition(s)
- Parkinson's Disease
Interventions
- Drug: Rasagiline | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 45 Years to 80 Years
Trial Duration
- 11/01/2012 - 01/01/2015
Phase
- Phase 4
Study Type
Interventional
